AMINOGLYCOSIDE PHOSPHOTRANSFERASE-II-MEDIATED AMIKACIN RESISTANCE IN ESCHERICHIA-COLI
AMINOGLYCOSIDE PHOSPHOTRANSFERASE-II-MEDIATED AMIKACIN RESISTANCE IN ESCHERICHIA-COLI
复制标题
DOI:
10.1128/aac.20.3.344
复制
发表时间:
1981-01-01
影响因子:
4.9
通讯作者:
KAPTIJN, GMP
中科院分区:
文献类型:
--
作者:
BONGAERTS, GPA;KAPTIJN, GMP
An E. coli strain with a plasmidic amikacin resistance was selected for which the evidence strongly indicates that resistance is mediated by aminoglycoside phosphotransferase [APH(3'')-II]. This resistance was coupled with resistance against kanamycin and neomycin. Partially purified APH(3'')-II [APH(3") free] modified amikacin by phosphorylation. The product of the APH(3'')-II mediated reaction (i.e., 3''-O-phosphoryl-amikacin) lost its antibacterial activity. The amikacin-modifying APH(3'')-II activity increased 5-10-fold after adaptation of the cells to higher concentrations of amikacin. The substrate spectrum of this enzyme showed a low activity against amikacin as compared with neomycin. It is argued that the enzyme level rather than its substrate spectrum is important for enzyme-mediated resistance. The increase in enzyme levels was correlated with an increase in copy number of a 110-Megadalton plasmid (pBN66) which coded for the APH(3'')-II and the APH(3") activity. The increase in copy number was irreversible and this phenomenon is ascribed to a mutation of a gene which affects the copy number. In transconjugants, the original low copy number was present and the mutation thus must be located on the chromosome and not on the plasmid.